Benzinga | Nov 2, 2020 07:41AM EST

Minerva Neurosciences Q3 EPS $(0.19) Beats $(0.23) Estimate

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.23) by 17.39 percent. This is a 47.22 percent increase over losses of $(0.36) per share from the same period last year.